加载中
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
最新数据
JP¥593
−JP¥12.00 · -1.98%
盘中时间采用JST。市场数据可能有所延迟。
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
日内区间
当前JP¥593
52周区间
当前JP¥593
盘中时间采用JST。市场数据可能有所延迟。
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
日内区间
当前JP¥593
52周区间
当前JP¥593
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（JPY） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 2.31亿 JPY | 5444.6万 JPY | 6111.2万 JPY | 3.74亿 JPY | 7.08亿 JPY |
| 销货成本 | 1.53亿 JPY | 5288.4万 JPY | 6149万 JPY | 1.51亿 JPY | 1.4亿 JPY |
| 毛利 | 7840万 JPY | 156.2万 JPY | −37.8万 JPY | 2.24亿 JPY | 5.68亿 JPY |
| 研究与开发 | — | 4.7亿 JPY | 3.76亿 JPY | 3.04亿 JPY | 2.66亿 JPY |
| 销售、一般及管理费用 | 9.07亿 JPY | 4.28亿 JPY | 3.21亿 JPY | 3.45亿 JPY | 2.31亿 JPY |
| 营业费用 | 9.07亿 JPY | 8.98亿 JPY | 6.97亿 JPY | 6.49亿 JPY | 4.98亿 JPY |
| 利息收入 | 380.7万 JPY | 48万 JPY | 4万 JPY | 4.1万 JPY | 17.6万 JPY |
| 利息支出 | 1427.9万 JPY | 951.4万 JPY | 977.4万 JPY | 745.7万 JPY | 523.6万 JPY |
| 折旧和摊销 | 3549.4万 JPY | 3601.7万 JPY | 3812.2万 JPY | 5428.5万 JPY | 1849.6万 JPY |
| 营业利润 | −8.28亿 JPY | −8.96亿 JPY | −6.97亿 JPY | −4.25亿 JPY | 7057万 JPY |
| 净利润 | −7.64亿 JPY | −8.72亿 JPY | −5.89亿 JPY | −4.74亿 JPY | 1.43亿 JPY |
公司数据更新于 2026年10月15日。
近期已公布业绩
近期已公布业绩
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
